Advertisement
Home 2016

Archives

It is anticipated that current and projected numbers of cardiothoracic surgeons will be unable to provide adequate caseload coverage by 2035

Cardiothoracic Surgeons May Not Meet 2035 Caseload

0
Anticipated increase of 61 percent in national caseload, 121 percent increase for each surgeon
For patients undergoing transcatheter aortic valve replacement

High Rate of Cerebral Embolization During TAVR

0
No significant differences in cerebral embolization measures during TAVR with bivalirudin vs. heparin
Precision cancer treatment that's guided by genetic clues from the patient's own tumor appears to improve outcomes

ASCO: Phase I Cancer Drug Trials Benefit From Precision Medicine

0
Better outcomes for patients whose treatment is selected based on molecular characteristics of tumor
For patients receiving an everolimus-eluting stent implantation

Adverse Events Not Up With Six Months of DAPT

0
Comparable results for 12-month DAPT among patients receiving everolimus-eluting stents
In an all-female transcatheter aortic valve replacement registry

Safety of TAVR Examined in All-Female Cohort

0
30-day VARC-2 composite end point for 14.0 percent of women undergoing TAVR for aortic stenosis
Earlier introduction to potentially allergenic foods may decrease the risk of sensitization

ATS: Feeding Infants Certain Foods Early May Cut Allergy Risk

0
Study supports turnaround in thinking about peanuts, eggs, and milk
Hospital patients may face an increased risk of death when medical residents leave their monthly rotations

ATS: Monthly Resident Hand-Off Tied to Higher Mortality Risk

0
Chances of death increase during transitions in care, study finds, but researchers not sure why
Survival odds for colorectal cancer may depend on which side of the colon the primary tumor develops

ASCO: Side of Colon Tumor Develops on Affects CRC Survival

0
Patients with primary tumors on left side live longer than those with primary tumors on right
Palliative care that's offered soon after a terminal cancer diagnosis can also help caregivers

ASCO: Early Palliative Care Beneficial for Caregivers

0
Such programs improve quality of life for people caring for terminal cancer patients
Use of pembrolizumab (Keytruda) in advanced melanoma is extending survival for many and even curing some

ASCO: Pembrolizumab Improves Survival in Melanoma

0
Three-year overall survival rate of 40 percent; median overall survival of 24.4 months